rekrunner wrote:
4) I can give my opinions, but I chose not to. My highly nuanced opinions will just infuriate you more. But as you insist, I will give a general summary of my beliefs in a separate post -- maybe that will help.
Sorry for the length, but you asked for this repeatedly.
Maybe addressing your questions generally about my beliefs can keep this and future threads much shorter, by stopping you from building strawmen beliefs that are not mine, only for me to deny them, only for you to say no one understands me, ad infinitum.
This is how I see doping working with performance:
- Doping works well for everybody, when their body is at less than its full potential, due to some physical deficiency, or simply a lack of training, that doping can quickly and artificially correct in the optimal direction. If the defiency is smaller, the potential effect is smaller. If there is no significant weakness, the gain will be smaller, or zero, or performance could degrade if doping moves fitness away from optimal.
- When we look at EPO, hypothetically, EPO would work well for sea-level athletes at sea-level, but would diminish for that same sea-level athlete if taken after some time at altitude, where natural EPO production has been stimulated by altitude, and RBC count becomes high, and much, if not all, of the aerobic benefit has been realized by natural means. A similar argument exists if EPO is taken at altitude. Whether the return from EPO in these altitude cases is marginal, or superfluous, needs more data to determine.
- This means that, still hypothetically, EPO can fail to work, or work not so much, for all athletes that have completed a long session of clean altitude training, but can also work well for all of these same athletes at other times, when they are at 80% aerobic fitness, to unnaturally arrive at 90% quickly. Note, this training shortcut can also be viewed as "cheating" and warrant a ban, even if the fitness is just 90%.
- Therefore, determining whether EPO, or any doping, can work or can fail needs to consider several other external factors relevant to that athlete at that moment.
- A weak mind can also lead to inferior training due to a lack of confidence. Some drugs which might otherwise have no effect, can unblock mental barriers and still produce improvements.
- Male hormones work especially well for women (with rare exceptions like AIS) in sprint and strength events, including middle and shorter distances.
- Those who experiment with drugs, will interpret any improvement as positive feedback, even if that improvement occurred simply from the training that he would have done anyway, or if improvements come from placebo effect. This contributes to an over-estimation in effect from personal anecdotes as in real life, doping and performance evaluation is not conducted in a controlled way.
- The limiter for the marathon is not aerobic, but other things, like efficiency, carbohydrate management, and, for larger runners and/or on hotter days, thermal. We saw this recently with Nike shoes, producing improvements in everyone due to attacking efficiency.
- One reason I downplay, but do not deny, blood doping benefit, can be found in at least two meta-survey studies, which draw the same conclusion that studies have tended to over-estimate the effect.
- Another reason I downplay any doping benefit can be found in more detail in my performance threads. This was the subject of lengthy debates, but generally, high prevalence and high effect should have had different expected results than what we have seen historically. Over the years I have given many examples of large groups who should have performed better, not only comparing against East and North Africans, but comparing non-Africans of today to non-Africans of the past. For example, Russian men should have been better in terms of quantity and depth of quality in the last 3 decades. Russian women should be better than the Japanese women, in the marathon.
- I don't believe doping can be widespread and highly effective and still produce single extreme outlier performers (like El G, or Paula) with unrepeatable performances, or target only specific narrow subsets of populations for decades (like Nandi or Oromo). These athletes may or may not be doped, but the reason for being extreme outliers have non-doping explanations.
- I don't believe that Kenya or Ethiopia had the funding or infrastructure to produce a large-scale doping operation, starting in the '90s, on a scale that would make Russia jealous, and could escape detection for decades, particularly when exported athletes training in Japan and USA perform well.
- East African domination showed some early signs of greatness in the 1960s (e.g. Bikila and Keino), and really started in 1981, in world cross country, and has continued to the present day.
- The reason for the apparent decline in track times is due more to changes like the change from Golden League to Diamond League, and less money on the track versus more money available on the roads, than to improvements in anti-doping.
- A lack of testing is not strong proof of doping.